Resources

For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Immuno-Oncology

Preclinical Strategies for Combination Immunotherapies

Oncology is almost always oriented towards simultaneous treatment options. We explore why as well as the approach’s unique challenges.
Bioanalysis

The Black Box Effect - How Can AI and ML Provide Transparent Insights for Drug Discovery?

We interview Martin Akerman, Chief Technology Officer and Co-Founder at Envisagenics to find out about machine learning for drug target discovery in RNA.
Bioanalysis

Nature Announces Top 10 R&D Institutes

The 2021 report is in, but who made the cut?
Peptide Chemistry

Migraine Drug Doubles its Sales, Despite Expansion Setback

Vyepti is the first intravenous medication approved for migraine treatment.
Vaccines

Will Vaccine Manufacturers go into Overdrive this Flu Season?

With influenza expected to make a return this winter, vaccine manufacturers may be facing more demand than usual.

Children in London to be Given Urgent Polio Booster Vaccine

Children between one and nine years old to be given polio jab to curb the spread of the virus throughout the city.
Manufacturing & Bioprocessing

In Conversation With Jenny Prange, Head of GMP Production, Chief Scientific Officer and Co-Founder of Muvon Therapeutics

The present and the future, key insights into the cell and gene therapy manufacturing space

China Warns of New Virus Transmitted by Shrews

How worrying is the new ‘Langya’ virus spreading in China?

Monkeypox Cases in UK Begin to Plateau

Statistics show that the number of people infected with the monkeypox virus is starting to slow down.
Antibody & Protein Engineering

AstraZeneca Suffers Sales Decline for COVID Med Evusheld

A 24 million loss has been reported for the preventative COVID-19 treatment.
Antibody & Protein Engineering

Market Battle for Rare Disease Treatment

Argenx and AstraZeneca are set to become market rivals in their general myasthenia gravis (gMG) treatments, analysts claim.
Immuno-Oncology

AAV Gene Therapy and CAR T Therapies: Immunogenicity and Immunoassay Development

Dr. Vibha Jawa, Executive Director, Nonclinical Disposition and Bioanalysis at BMS

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery